CNTG (Centogene N.V.) צמיחת מכירות רבעונית

Centogene N.V. (CNTG) leads in the identification of rare pathologies by collaborating with developers of orphan drugs. Quarterly revenue growth rates link this success to the ownership of a massive biobank in Europe. Stability is guaranteed by the neutral status of biomedicine in global politics. The current -8.40 indicator determines the status of the business activity parameter, helping investors assess the real potential for the company's long-term sales acceleration.
פילוחים אנליטיים ודוחות נתונים של חברת CENTOGENE N.V. (CNTG)

To select high-quality assets, investors utilize revenue dynamics as a filter for operational efficiency and market potential. This indicator measures the percentage deviation of current quarterly sales from the same period last year, which for Centogene N.V. (CNTG) reflects the monetization of its genetic database through the sale of reports to pharmaceutical companies, clearly capturing the pace of business scaling via quarter-over-quarter sales growth.